Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Tissue Cell ; 46(6): 505-13, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25287887

ABSTRACT

Disc degeneration alters disc height and mechanics of the spinal column and is associated with lower back pain. In preclinical studies gel-like materials or resorbable polymer-based implants are frequently used to rebuild the nucleus pulposus, aiming at tissue regeneration and restoration of tissue function. To compare the outcome of tissue repair, freeze-dried resorbable polyglycolic acid-hyaluronan (PGA/HA) implants without any bioactive components or bioactivated fibrin (fibrin-serum) was used in a degenerated disc disease model in New Zealand white rabbits. Animals with partial nucleotomy only served as controls. The T2-weighted/fat suppression sequence signal intensity in the nuclear region of operated discs as assessed by magnet resonance imaging was reduced in operated compared to healthy discs, indicating loss of water and did not change from week 1 to month 6 after surgery. Quantification of histological and immunohistochemical staining indicated that the implantation of PGA/HA leads to significantly more repair tissue compared to nucleotomy only. Type II collagen content of the repair tissue formed after PGA/HA or fibrin-serum treatment is significantly increased compared to controls with nucleotomy only. The data indicate that intervertebral disc augmentation after nucleotomy has a positive effect on repair tissue formation and type II collagen deposition as shown in the rabbit model.


Subject(s)
Intervertebral Disc Degeneration/therapy , Intervertebral Disc/pathology , Low Back Pain/therapy , Regeneration , Absorbable Implants , Animals , Collagen Type II/metabolism , Disease Models, Animal , Diskectomy, Percutaneous , Humans , Hyaluronic Acid/administration & dosage , Intervertebral Disc/surgery , Intervertebral Disc Degeneration/pathology , Low Back Pain/pathology , Polyglycolic Acid/administration & dosage , Rabbits
2.
Tissue Cell ; 41(6): 414-20, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19631359

ABSTRACT

The aims of this work were to test whether human intervertebral disc-derived nucleus pulposus cells (hNP-cells) are attracted by human serum and to analyze if matrix generation from hNP-cells is promoted under the influence of transforming growth factor-beta3 (TGF-beta3) or hyaluronan (HA) in vitro. Using the multi-well chemotaxis assay to determine cell migration under the influence of different concentrations of human serum, it was demonstrated that dedifferentiated hNP-cells are able to migrate towards a serum fraction gradient in a concentration-dependent manner. Re-differentiation capacity of hNP-cells in 3D micro-masses under the influence of TGF-beta3 or hyaluronan was also tested. Gene expression analysis of types I, II, III and IX collagen, as well as aggrecan, COMP and LINK of hNP-cells in 3D-micro-mass cell-culture revealed a strong increase of these markers in TGF-beta3 treated cells. Furthermore, histochemical and immuno-histochemical staining after 28d showed proteoglycan and type II collagen-rich matrix for both, the TGF-beta3 and the hyaluronan treated cells. These findings show that TGF-beta3 or hyaluronan are able to induce the differentiation and that human serum stimulates the migration of hNP-cells in vitro. Therefore, hyaluronan and serum are suited for cell-free biomaterials as cell migration and differentiation inducing factors intended for biological treatment strategies of the intervertebral disc.


Subject(s)
Hyaluronic Acid/pharmacology , Intervertebral Disc/cytology , Intervertebral Disc/metabolism , Serum , Transforming Growth Factor beta3/pharmacology , Viscosupplements/pharmacology , Cell Dedifferentiation/drug effects , Cell Dedifferentiation/physiology , Cell Movement/drug effects , Cell Movement/physiology , Cells, Cultured , Extracellular Matrix/metabolism , Extracellular Matrix Proteins/biosynthesis , Humans
3.
Placenta ; 28(7): 688-700, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17129602

ABSTRACT

It remains arguable if an animal model can be of use in pre-eclampsia (PE) studies, as it is clearly a human disease not observed spontaneously in other species. The aim of this study was to investigate whether PE-like signs in mice inoculated with activated Th1 cells were accompanied by abnormal expression of molecules related to the regulation of blood pressure, viz. nitric oxide synthase enzymes (eNOS and iNOS) and angiotensin (Ang) II receptors (AT1R and AT2R), in order to analyse the relevance of this model for human disease. In this model, C57/BL6-mated BALB/c females received lymphocytes crosslined with anti-CD3 and cultured with interleukin (IL)-2 and IL-12 to mimic PE pathology. Control mice received PBS. eNOS, iNOS and AT1R but not AT2R expression was augmented in the kidneys of PE-mice compared with control pregnant mice. The expression of eNOS but not of iNOS was augmented at the fetal-maternal interface of PE-mice as compared with the controls. NOSs regulate the synthesis of NO, a blood pressure and parturition mediator. As its expression is increased in PE patients, our data suggest that the Th1 cells-induced signs in this model are due to similar mechanisms as in humans. AT1R and AT2R mediate the effect of Ang II, and particularly the AT1R appears to be involved in the pathogenesis of human PE. The increased AT1R expression in the kidneys of PE-mice reinforces the theory that Th1 cells elicit a pathological situation closely resembling the human PE. All together, our data support the use of this animal model to study mechanisms underlying clinically overt PE.


Subject(s)
Disease Models, Animal , Kidney/metabolism , Mice/immunology , Nitric Oxide Synthase Type III/metabolism , Placenta/metabolism , Pre-Eclampsia/immunology , Receptor, Angiotensin, Type 1/metabolism , Adoptive Transfer , Animals , Female , Immune System , Kidney/chemistry , Kidney/pathology , Mice, Inbred Strains , Nitric Oxide Synthase Type II/analysis , Nitric Oxide Synthase Type II/genetics , Nitric Oxide Synthase Type II/metabolism , Nitric Oxide Synthase Type III/analysis , Nitric Oxide Synthase Type III/genetics , Placenta/chemistry , Placenta/pathology , Pregnancy , RNA, Messenger/metabolism , Receptor, Angiotensin, Type 1/analysis , Receptor, Angiotensin, Type 2/analysis , Receptor, Angiotensin, Type 2/metabolism , Th1 Cells/immunology , Th1 Cells/transplantation , Up-Regulation
4.
Scand J Immunol ; 61(6): 492-502, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15963043

ABSTRACT

Several burning questions remain unanswered in pregnancy-related research. Pro- and anti-inflammatory cytokines orchestrate an intriguing interaction leading either to the development of a normal individual or to its rejection. Augmented Th1 cytokines' production is involved in immunological rejection of the foetus. Excessive production of Th1 cytokines, particularly of tumour necrosis factor (TNF)-alpha, also triggers apoptosis. Thus, in the present work we investigated the incidence of apoptosis in a well-known experimental model of Th1-induced abortion, characterized by increased local TNF-alpha levels. Apoptosis of lymphocytes as well as their Th1 and Th2 cytokine production were analysed by flow cytometry. TNF-alpha mRNA levels were additionally analysed by real time reverse transcription-polymerase chain reaction (RT-PCR) in placental and decidual samples. Total placental apoptosis activity was investigated by measuring caspase-3 activity and by TdT-mediated dUTP nick end label staining. Immunohistochemistry, Western blot and real time RT-PCR were used to localize and quantify several anti- and pro-apoptotic molecules at the foetal-maternal interface. Despite elevated Th1 levels at the foetal-maternal interface, mice undergoing abortion presented comparable apoptotic rates. Interestingly, we found a significant upregulation of the anti-apoptotic Bcl-2 protein at the foetal-maternal interface from abortion-prone mice, while no changes could be observed for pro-apoptotic molecules. In the light of our results, we conclude that there is no evidence of increased apoptosis in mice undergoing immunological abortion in spite of elevated TNF-alpha levels. This is probably due to a selective upregulation of anti-apoptotic pathways (i.e. Bcl-2) at the foetal-maternal interface as a compensatory and/or protective mechanism.


Subject(s)
Abortion, Spontaneous/metabolism , Placenta/metabolism , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Abortion, Spontaneous/immunology , Animals , Decidua/immunology , Decidua/metabolism , Female , Male , Mice , Mice, Inbred CBA , Mice, Inbred DBA , Placenta/immunology , Polymerase Chain Reaction , Pregnancy , RNA, Messenger/analysis , Th1 Cells/immunology , Tumor Necrosis Factor-alpha/biosynthesis , Tumor Necrosis Factor-alpha/genetics , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL
...